Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 5Head & Neck 4Thoracic 3Sarcoma 1Lymphoid 1Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Lymphoma 41Lymphoma, Large B-Cell, Diffuse 31Lymphoma, Non-Hodgkin 28Lymphoma, Follicular 21Lymphoma, Large-Cell, Immunoblastic 17Hodgkin Disease 16Lymphoma, Mantle-Cell 15Burkitt Lymphoma 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Leukemia, Lymphocytic, Chronic, B-Cell 9Recurrence 8Lymphoma, Large-Cell, Anaplastic 8Lymphoma, B-Cell, Marginal Zone 6Waldenstrom Macroglobulinemia 5Lymphoma, B-Cell 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasms 4Lymphoma, Extranodal NK-T-Cell 4Immunoblastic Lymphadenopathy 4Neoplasm Metastasis 3Lymphoma, T-Cell, Peripheral 3Lymphoma, T-Cell, Cutaneous 3Mesothelioma 2Lymphoma, T-Cell 2Leukemia 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Uveal Melanoma 1Sezary Syndrome 1Primary Myelofibrosis 1

Interventions

Cyclophosphamide 2tanespimycin 1entinostat 1Vorinostat 1Thiotepa 1Thalidomide 1SUB1 protein, human 1Ritonavir 1Radiotherapy 1Peripheral Blood Stem Cell Transplantation 1Nicotine 1Indinavir 1Filgrastim 1Fentanyl 1Etoposide 1Docetaxel 1Cryosurgery 1Cisplatin 1Chemotherapy, Adjuvant 1Carmustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esthesioneuroblastoma, Olfactory × Cisplatin × Lymphoid × Clear all
NCT00007982 2013-02-04

Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer

National Cancer Institute (NCI)

Phase 2 Completed
30 enrolled
CNSHead & NeckLymphoid

Astrocytoma, Brain Neoplasms, Head and Neck Neoplasms, Lymphoma, Medulloblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡